Ehrlich Christopher B
- SEC CIK
- 0001293973
No open-market purchases or sales filed in the past year.
Current role at each company
- CERO Cero Therapeutics Holdings, Inc.Chairman and CEOas of Jan 9, 2026
- CIK 0001828522Directoras of Jun 13, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Ehrlich Christopher B as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
CIK 0001828522
Director6 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Oct 6, 2022 (view filing) | Oct 4 | 2 days | Ehrlich Christopher BDirector | PPurchase | +346 | $0.57 | +$197.22 | +1.0%35.2K after | |
| Sep 27, 2022 (view filing) | Sep 26 | 1 day | Ehrlich Christopher BDirector | PPurchase | +18.9K | $0.55 | +$10.4K | +117.9%34.9K after | |
| Feb 22, 2022 (view filing) | Feb 14-18 | 8 daysLate | Ehrlich Christopher BDirector | PPurchase | +3.00K | $4.40 | +$13.2K | +23.1%16.0K after | 2 lots |
| Feb 10, 2022 (view filing) | Feb 8-9 | 2 days | Ehrlich Christopher BDirector | PPurchase | +2.00K | $4.84 | +$9.67K | +18.2%13.0K after | 2 lots |
| Feb 7, 2022 (view filing) | Feb 3-4 | 4 days | Ehrlich Christopher BDirector | PPurchase | +6.00K | $5.13 | +$30.8K | +120.0%11.0K after | 2 lots |
| Jan 31, 2022 (view filing) | Jan 27 | 4 days | Ehrlich Christopher BDirector | PPurchase | +5.00K | $5.30 | +$26.5K | New position5.00K after |